FDA Inspection
Laclede, Inc.Laclede, Inc. – FDA Inspection, Sep 4, 2013
Record Details
This FDA Inspection record concerns Laclede, Inc., with an inspection on September 4, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Laclede, Inc.
- Inspection Date
- September 4, 2013
- Product Type
- Drugs
View Company Profile
ID · 64061516-b3d6-4ded-ac94-229bad498f7f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 848328
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
FDA Citations
2- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.165(a)Testing and release for distribution
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Laclede, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2018 | Not classified | Los Angeles District Office | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| June 27, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 13, 2011 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| September 10, 2010 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Laclede, Inc.
- FDA Inspection 1071099 - 2018-11-07
- FDA Inspection 788585 - 2012-06-27
- FDA Inspection 737009 - 2011-07-13
- FDA Inspection 681079 - 2010-09-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.